Joseph Edelman – NRIX history
- Issuer:
- NURIX THERAPEUTICS INC
- Quarters tracked:
- 7 (Q4 2024 → Q2 2026)
- Current shares:
- 4,320,422
- Current value:
- $104.81M
- Peak shares:
- 4,320,422 (Q2 2026)
- Overall change:
- +1207%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 4,320,422 | $104.81M | $24.26 | +609,545 | +16% |
| Q1 2026 | 3,710,877 | $57.52M | $15.50 | +155,000 | +4% |
| Q4 2025 | 3,555,877 | $67.45M | $18.97 | +2,139,728 | +151% |
| Q3 2025 | 1,416,149 | $13.09M | $9.24 | +319,164 | +29% |
| Q2 2025 | 1,096,985 | $12.49M | $11.39 | +799,432 | +269% |
| Q1 2025 | 297,553 | $3.54M | $11.88 | -33,061 | -10% |
| Q4 2024 | 330,614 | $6.23M | $18.84 | — | NEW |